Articles with public access mandates - Christoph Correll; Christoph U CorrellLearn more
Not available anywhere: 106
Review
Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies
T Kishimoto, M Nitta, M Borenstein, JM Kane, CU Correll
J Clin psychiatry 74 (10), 957-965, 2013
Mandates: US National Institutes of Health
Review
Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
AJ Mitchell, V Delaffon, D Vancampfort, CU Correll, M De Hert
Psychological medicine 42 (1), 125-147, 2012
Mandates: US National Institutes of Health
Review
Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents
L Maayan, CU Correll
Journal of child and adolescent psychopharmacology 21 (6), 517-535, 2011
Mandates: US National Institutes of Health
Review
Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia
M Carbon, CU Correll
CNS spectrums 19 (S1), 35-53, 2014
Mandates: US National Institutes of Health
Review
Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo …
CU Correll, EM Sheridan, MP DelBello
Bipolar disorders 12 (2), 116-141, 2010
Mandates: US National Institutes of Health
Review
Inflammatory cytokines and anorexia nervosa: A meta-analysis of cross-sectional and longitudinal studies
M Solmi, N Veronese, A Favaro, P Santonastaso, E Manzato, G Sergi, ...
Psychoneuroendocrinology 51, 237-252, 2015
Mandates: US National Institutes of Health
Review
Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second‐generation antipsychotics
CU Correll, AM Frederickson, JM Kane, P Manu
Bipolar disorders 10 (7), 788-797, 2008
Mandates: US National Institutes of Health
Review
The bipolar prodrome: meta-analysis of symptom prevalence prior to initial or recurrent mood episodes
AR Van Meter, C Burke, EA Youngstrom, GL Faedda, CU Correll
Journal of the American Academy of Child & Adolescent Psychiatry 55 (7), 543-555, 2016
Mandates: US National Institutes of Health
Review
Efficacy and safety of atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression
S Schwartz, CU Correll
Journal of the American Academy of Child & Adolescent Psychiatry 53 (2), 174-187, 2014
Mandates: US National Institutes of Health
Review
Worldwide differences in regulations of clozapine use
J Nielsen, C Young, P Ifteni, T Kishimoto, YT Xiang, PFJ Schulte, ...
CNS drugs 30 (2), 149-161, 2016
Mandates: US National Institutes of Health
Review
Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?
R Røge, BK Møller, CR Andersen, CU Correll, J Nielsen
Schizophrenia research 140 (1-3), 204-213, 2012
Mandates: US National Institutes of Health
Review
NCDEU FEstsChriFt
CU Correll, CJ Kratochvil, JS March
J Clin Psychiatry 72 (5), 655-670, 2011
Mandates: US National Institutes of Health
Review
A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with …
JM Kane, CU Correll, DC Goff, B Kirkpatrick, SR Marder, ...
Journal of clinical psychiatry 70 (10), 1348, 2009
Mandates: US National Institutes of Health
Review
Clinical characteristics and predictors of outcome of schizophrenia-spectrum psychosis in children and adolescents: a systematic review
M Stentebjerg-Olesen, AK Pagsberg, A Fink-Jensen, CU Correll, ...
Journal of child and adolescent psychopharmacology 26 (5), 410-427, 2016
Mandates: US National Institutes of Health
Review
Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis
AK Pagsberg, S Tarp, D Glintborg, AD Stenstrøm, A Fink-Jensen, ...
Journal of the American Academy of Child & Adolescent Psychiatry 56 (3), 191-202, 2017
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Review
The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder
T Kishi, R Yoshimura, Y Fukuo, T Okochi, S Matsunaga, ...
European archives of psychiatry and clinical neuroscience 263, 105-118, 2013
Mandates: US National Institutes of Health
Review
Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study
J Nielsen, RE Nielsen, CU Correll
Journal of clinical psychopharmacology 32 (5), 678-683, 2012
Mandates: US National Institutes of Health
Review
Treatment of adolescents with early-onset schizophrenia spectrum disorders: in search of a rational, evidence-informed approach
BG Schimmelmann, SJ Schmidt, M Carbon, CU Correll
Current opinion in psychiatry 26 (2), 219-230, 2013
Mandates: US National Institutes of Health
Review
Aripiprazole for the treatment of pediatric bipolar I disorder: A 30‐week, randomized, placebo‐controlled study
RL Findling, CU Correll, M Nyilas, RA Forbes, RD McQuade, N Jin, ...
Bipolar Disorders 15 (2), 138-149, 2013
Mandates: US National Institutes of Health
Review
Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia
B Galling, JA Vernon, AK Pagsberg, A Wadhwa, E Grudnikoff, ...
Acta Psychiatrica Scandinavica 137 (3), 187-205, 2018
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program